Per the Food and Drug Omnibus Reform Act of 2022, the U.S. Food and Drug Administration asked the National Academies to examine and report on the state of the science regarding methodologies for assessing the biological quality of protein in infant formula and the ability of infant formula to support normal physical growth. The committee's statement of task noted that its analysis should include the examination of current study designs and methods that could demonstrate quality factors have been met. The resulting report presents conclusions, recommendations, and areas of future research to improve standardized procedures for assessing protein quality in infant formula.
Per the Food and Drug Omnibus Reform Act of 2022, the U.S. Food and Drug Administration asked the National Academies to examine and report on the state of the science regarding methodologies for assessing the biological quality of protein in infant formula and the ability of infant formula to support normal physical growth. The committee's statement of task noted that its analysis should include the examination of current study designs and methods that could demonstrate quality factors have been met. The resulting report presents conclusions, recommendations, and areas of future research to improve standardized procedures for assessing protein quality in infant formula.

Protein Quality and Growth Monitoring Studies: Quality Factor Requirements for Infant Formula
220
Protein Quality and Growth Monitoring Studies: Quality Factor Requirements for Infant Formula
220Paperback
Product Details
ISBN-13: | 9780309735216 |
---|---|
Publisher: | National Academies Press |
Publication date: | 02/05/2026 |
Pages: | 220 |
Product dimensions: | 6.00(w) x 9.00(h) x (d) |